DP down‐regulated the expression of MFG‐E8, reduced mitophagy deficiency, and alleviated the symptoms of diabetic sarcopenia, which could be considered a novel therapeutic strategy for diabetic sarcopenia. This evidence concerns the gene MFGE8 and diabetes mellitus.